Search This Blog

Thursday, August 1, 2019

Premarket analyst action

Khiron Life Sciences (OTCQB:KHRNF) initiated with Speculative Buy rating at Alta.
AMAG Pharmaceuticals (NASDAQ:AMAG) initiated with Buy rating and $16 (94% upside) price target at H.C. Wainwright.
United Therapeutics (NASDAQ:UTHR) upgraded to Buy with a $106 (34% upside) price target at Ladenburg Thalmann. Upgraded to Hold with a $90 price target at Jefferies.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.